Sysmex (OTCMKTS:SSMXY) Issues Quarterly Earnings Results

Sysmex (OTCMKTS:SSMXY) posted its quarterly earnings results on Wednesday. The company reported $0.17 earnings per share for the quarter, Zacks reports. Sysmex updated its FY 2024 guidance to 0.580-0.580 EPS.

Sysmex Stock Down 0.3 %

Shares of Sysmex stock traded down $0.06 during midday trading on Thursday, reaching $18.22. 75,584 shares of the company’s stock traded hands, compared to its average volume of 84,987. The company has a market cap of $11.47 billion, a price-to-earnings ratio of 36.91 and a beta of 0.90. The company’s 50 day simple moving average is $18.86 and its 200 day simple moving average is $19.02. Sysmex has a 52 week low of $14.38 and a 52 week high of $28.58. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.42 and a current ratio of 3.19.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.